Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 14 (2) , 63-73
- https://doi.org/10.1016/s0885-3924(97)00012-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Single Dose Pharmacokinetics of Kapanol™, a New Oral Sustained-Release Morphine FormulationClinical Drug Investigation, 1994
- Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer.Journal of Clinical Oncology, 1993
- Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients — a comparison of two oral formulationsEuropean Journal of Clinical Pharmacology, 1991
- Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patientsCancer, 1989
- Effects of intervention on antibiotic compliance in patients in general practiceThe Medical Journal of Australia, 1987
- A study of controlled-release oral morphine (Ms Contin) in an advanced cancer hospitalJournal of Pain and Symptom Management, 1987